Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

US Army funds AndCare's gene probe

This article was originally published in Clinica

  • News

Executive Summary

AndCare has received $750,000 from the US Army to fund its portable DNA biosensors research. The Army stresses that it is interested in commercial as well as military applications of the gene probe, says Dr Robert Henkens, AndCare's chairman and CSO. The company, based in Research Triangle Park, North Carolina, is developing a battery-operated, hand-held monitor that uses mass-produced, calibrated, disposable sensor electrodes.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

Senseonics Wins Marketing Authorization For Novel Insulin Delivery System

Liquid Biopsy Company Karius Raised $100M To Expand Its Test For Detecting Over 1,000 Pathogens

Global Medtech Guidance Tracker: April 2024

Front Line Medical Technologies Announce CE Mark For COBRA-OS

See All
UsernamePublicRestriction

Register

MT088098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By